NEUROMYELITIS OPTICA SPECTRUM DISORDERS
Clinical trials for NEUROMYELITIS OPTICA SPECTRUM DISORDERS explained in plain language.
Never miss a new study
Get alerted when new NEUROMYELITIS OPTICA SPECTRUM DISORDERS trials appear
Sign up with your email to follow new studies for NEUROMYELITIS OPTICA SPECTRUM DISORDERS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for NMOSD: drug aims to slash relapse rate in chinese patients
Disease control OngoingThis study tests eculizumab in 21 Chinese adults with a severe autoimmune disease called NMOSD that attacks the nerves. The goal is to see if the drug can reduce the number of relapses and slow disability. Participants must already be on stable immunosuppressant medication, which…
Matched conditions: NEUROMYELITIS OPTICA SPECTRUM DISORDERS
Phase: PHASE3 • Sponsor: Alexion Pharmaceuticals, Inc. • Aim: Disease control
Last updated May 14, 2026 12:04 UTC
-
10,000 brains mapped: new charts could revolutionize diagnosis of Alzheimer's, MS, and stroke
Diagnosis ENROLLING_BY_INVITATIONThis study aims to create detailed brain charts for the Chinese population by collecting MRI scans from over 10,000 healthy volunteers of all ages. These charts will show what a normal brain looks like at different ages, helping doctors spot diseases like multiple sclerosis, Alzh…
Matched conditions: NEUROMYELITIS OPTICA SPECTRUM DISORDERS
Sponsor: Beijing Tiantan Hospital • Aim: Diagnosis
Last updated May 13, 2026 16:00 UTC